Physician profile
Jayakumar Sreenivasan
NPI 1821541061
$32,869.61
in general payments reported to CMS, 2019-2025
19 companies · $1,366 in 2025
The $1,366 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $823 · 2020: $211 · 2021: $4,046 · 2022: $3,096 · 2023: $18K · 2024: $5,511 · 2025: $1,366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $11K · Travel and Lodging: $8,480 · Food and Beverage: $5,527 · Education: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,500.00 |
| Travel and Lodging | $8,480.43 |
| Food and Beverage | $5,526.62 |
| Education | $186.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16,140.46 | 2021-2025 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $4,411.08 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Abbott Laboratories | $2,864.87 | 2023-2025 | Mitraclip, Optis, Cardiomems |
| Boston Scientific Corporation | $1,872.03 | 2019-2025 | General - Balloon Catheters |
| Csl Behring | $1,732.71 | 2021 | |
| W. L. Gore & Associates, INC. | $1,681.52 | 2024-2025 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder |
| Shockwave Medical, INC | $982.73 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $514.93 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $505.71 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $416.75 | 2019-2022 | |
| Chiesi USA, INC. | $371.77 | 2021 | |
| Cardiovascular Systems INC. | $336.80 | 2021-2023 | Diamondback Peripheral |
| Astellas Pharma US INC | $297.00 | 2019-2020 | |
| Heartflow, INC. | $256.23 | 2023 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $218.14 | 2019-2025 | Lifevest |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $106.54 | 2023 | Impella |
| Inari Medical, INC. | $71.23 | 2021 | |
| Medtronic Vascular, INC. | $64.80 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayakumar Sreenivasan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.